Pizotifen or pizotyline

This classification denotes a serotonin antagonist with the molecular formula C19H21NS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0BY8440V3N, chemically known as 4-(9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thien-4-ylidene)-1-methylpiperidine but generally known as pizotifen, which bears US NIH Compound Identifier 27400. European Medicines Agency schedules Pizotifen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09954MIG. The term PIZOTIFEN is an International Non-Proprietary Name. World Health Organization schedules pizotifen in its Anatomical Therapeutic Chemical (ATC) Classification. PIZOTIFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Pizotifen or pizotyline bears US NLM identifiers UMLS ID C0032036 and NCI Concept Code C87214. SMILES: s1c2c(C(=C3\CCN(CC3)C)/c3c(CC2)cccc3)cc1.